TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
VSTM

Verastem Inc

Healthcare · Biotechnology

7.40$ -1.5% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Verastem Inc (VSTM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 31 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement VSTM
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.0 0.0 0.0 0.0 27 17 89 2.1 2.6 0.0 10 31
0.4 0.8 0.7 0.6 0.6 2.8 34 0.2 0.1 0.1 0.0 5.3
-0.4 -0.8 -0.7 -0.6 26 15 55 2.1 2.6 -0.1 10 26
35 41 20 46 44 46 41 39 51 61 81 115
18 18 17 21 77 101 63 24 25 28 44 81
53 58 36 67 121 147 104 63 76 92 125 196
-54 -58 -37 -68 -95 -132 -49 -61 -73 -92 -115 -170
0.0 0.0 0.0 0.6 5.8 21 16 10.0 2.1 4.1 4.6 1.1
-53 -58 -36 -68 -72 -149 -68 -71 -74 -87 -130 -209
0.0 -0.8 0.0 0.6 28 20 0.2 9.9 0.0 -87 0.2
-53 -58 -36 -68 -72 -149 -68 -71 -74 -87 -131 -209
-53 -57 -36 -67 -65 -126 -50 -61 -72 -83 -126 -208

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?